Two pro-inflammatory cytokines that have been consistently linked to the pathophysiology of depression—particularly of TRD—are IL-6 and IL-8; their elevated levels have been associated with increased neuroinflammation, impaired neuroplasticity, and resistance to standard antidepressant therapies [7,8]. This evidence concerns the gene IL6 and depressive symptom measurement.